Revised diagnostic criteria of multiple sclerosis

Area of Science:

• Neurology
• Immunology
• Neuroscience

Background:

• Multiple sclerosis (MS) is a chronic, autoimmune central nervous system (CNS) demyelinating disease.
• MS is characterized by inflammation, demyelination, axonal loss, and gliosis, with variable clinical presentations.
• Recognized MS types include relapsing-remitting (RR), primary-progressive (PP), secondary-progressive (SP), progressive-relapsing (PR), and clinically-isolated syndrome (CIS).

Purpose of the Study:

• To review the evolution and application of diagnostic criteria for multiple sclerosis.
• To highlight the role of clinical judgment and neuroimaging in MS diagnosis.
• To discuss the implications of updated diagnostic criteria in clinical practice and research.

Main Methods:

• Review of historical and current diagnostic criteria for MS, including Schumacher, Poser, and McDonald criteria.
• Emphasis on the principles of dissemination in space (DIS) and dissemination in time (DIT).
• Inclusion of magnetic resonance imaging (MRI) advancements in diagnostic guidelines.

Main Results:

• Diagnostic criteria have evolved to improve sensitivity and specificity for MS detection.
• The 2001 and 2010 McDonald criteria incorporated MRI findings to aid diagnosis, especially after a clinically-isolated syndrome (CIS).
• The latest criteria simplify DIS and DIT requirements, potentially allowing earlier MS diagnosis via baseline MRI.

Conclusions:

• MS diagnosis remains primarily clinical, requiring careful evaluation and differential diagnosis.
• Advancements in diagnostic criteria, particularly the McDonald criteria, facilitate earlier and more accurate MS detection.
• Ongoing evaluation of diagnostic criteria's clinical utility and impact on trials is essential.